位置:首页 > 蛋白库 > ILIB_NEOS2
ILIB_NEOS2
ID   ILIB_NEOS2              Reviewed;         381 AA.
AC   P0DO31;
DT   02-JUN-2021, integrated into UniProtKB/Swiss-Prot.
DT   02-JUN-2021, sequence version 1.
DT   03-AUG-2022, entry version 5.
DE   RecName: Full=Trans-enoyl reductase iliB {ECO:0000303|PubMed:31216742};
DE            EC=1.-.-.- {ECO:0000269|PubMed:31216742};
DE   AltName: Full=Ilicicolin H biosynthesis cluster protein B {ECO:0000303|PubMed:31216742};
GN   Name=iliB {ECO:0000303|PubMed:31216742};
OS   Neonectria sp. (strain DH2).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes;
OC   Hypocreomycetidae; Hypocreales; Nectriaceae; Neonectria;
OC   unclassified Neonectria.
OX   NCBI_TaxID=1735992;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], FUNCTION, CATALYTIC
RP   ACTIVITY, AND PATHWAY.
RX   PubMed=31216742; DOI=10.3390/molecules24122267;
RA   Lin X., Yuan S., Chen S., Chen B., Xu H., Liu L., Li H., Gao Z.;
RT   "Heterologous expression of ilicicolin H biosynthetic gene cluster and
RT   production of a new potent antifungal reagent, ilicicolin J.";
RL   Molecules 24:0-0(2019).
CC   -!- FUNCTION: Trans-enoyl reductase; part of the gene cluster that mediates
CC       the biosynthesis of ilicicolin H, a 4-hydroxy-2-pyridonealkaloid that
CC       has potent and broad antifungal activities by inhibiting the
CC       mitochondrial respiration chain (PubMed:31216742). IliB collaborates
CC       with the hybrid PKS-NRPS synthetase iliA to assemble the backbone of
CC       ilicicolin H (PubMed:31216742). The PKS portion of iliA and trans-
CC       acting enoyl reductase iliB work together to construct an octaketide,
CC       and two methyl groups are introduced by the MT domain of iliA during
CC       the chain assembly (PubMed:31216742). The nascent chain is then
CC       condensed with tyrosine, catalyzed by the iliA C domain, and the
CC       resulting PKS-NRPS hybrid is offloaded by the iliA RED domain to form
CC       an advanced tetramic acid intermediate (PubMed:31216742). The
CC       biosynthesis of ilicicolin H starts with formation of the tetramic acid
CC       by the hybrid PKS-NRPS synthetase iliA with the partnering trans-enoyl
CC       reductase iliB since iliA lacks a designated enoylreductase (ER)
CC       domain. The cytochrome P450 monooxygenase iliC then catalyzes the ring
CC       expansion of the tetramate to the acyclic 2-pyridone. The pericyclase
CC       iliD further converts the acyclic 2-pyridone into 8-epi-ilicicolin H.
CC       8-epi-ilicicolin H might then spontaneously convert to ilicicolin H
CC       since ilicicolin H is produced in the absence of the epimerase iliE, in
CC       contrast to what was observed for the Talaromyces variabilis ilicolin H
CC       biosynthetic pathway (PubMed:31216742) (Probable).
CC       {ECO:0000269|PubMed:31216742, ECO:0000305|PubMed:31216742}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-[(4E,6E,10S,12Z,14E)-6,10-dimethyl-3-oxohexadeca-4,6,12,14-
CC         tetraenoyl]-L-tyrosyl-[ACP] = (3E,5S)-3-[(2E,4E,8S,10E,12Z)-1-
CC         hydroxy-4,8-dimethyltetradeca-2,4,10,12-tetraen-1-ylidene]-5-[(4-
CC         hydroxyphenyl)methyl]pyrrolidine-2,4-dione + H(+) + holo-[ACP];
CC         Xref=Rhea:RHEA:64548, Rhea:RHEA-COMP:9685, Rhea:RHEA-COMP:16623,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:64479, ChEBI:CHEBI:155890,
CC         ChEBI:CHEBI:155893; Evidence={ECO:0000269|PubMed:31216742};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64549;
CC         Evidence={ECO:0000269|PubMed:31216742};
CC   -!- PATHWAY: Mycotoxin biosynthesis. {ECO:0000269|PubMed:31216742}.
CC   -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:Q9Y7D0}.
CC   -!- SIMILARITY: Belongs to the zinc-containing alcohol dehydrogenase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   AlphaFoldDB; P0DO31; -.
DR   SMR; P0DO31; -.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR   InterPro; IPR013149; ADH-like_C.
DR   InterPro; IPR011032; GroES-like_sf.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR020843; PKS_ER.
DR   Pfam; PF00107; ADH_zinc_N; 1.
DR   SMART; SM00829; PKS_ER; 1.
DR   SUPFAM; SSF50129; SSF50129; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
PE   1: Evidence at protein level;
KW   NADP; Nucleotide-binding; Oxidoreductase.
FT   CHAIN           1..381
FT                   /note="Trans-enoyl reductase iliB"
FT                   /id="PRO_0000453068"
FT   BINDING         50..53
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y7D0"
FT   BINDING         145..152
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255"
FT   BINDING         213..216
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y7D0"
FT   BINDING         231
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y7D0"
FT   BINDING         278..279
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y7D0"
FT   BINDING         298..302
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255"
FT   BINDING         367..368
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y7D0"
SQ   SEQUENCE   381 AA;  40275 MW;  B319067A6D60A27D CRC64;
     MALATPLPAT QAAVKVTGPS TVDVSAATTL PVLEAFEVLV RVACVSINHV DGKSADMSPT
     PGATSGVDFS GLIVALGSKV DSDEFRANNN MRALSIGDRV FGGVFGNNPL RHDNGAFAEY
     VAVPARLIWH MPAAMDFSTA ATIGATLATV GLALFQYLQV PMPSTQTISD SKTIPDPQQK
     TRMALVYGGG TATGAMAIQV LKLAGFRPIT TCSPGSAARA MHLGAAATFD YRSPTCGADL
     REHTANGLEL ALDCITDTAS MSICYEALGS AGGRYVALDA FPLRGHTRRS VAAEWVCTYT
     QFGHAVAWVP PYNLDARPRD REIAEAWYVV AQQLVDEGLI EPYPKEDRTG GLAAVGEGMR
     AVWKGEISGR KLAYPIAEEC Y
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024